SC
MDT icon

Scotia Capital’s Medtronic MDT Stock Holding History

Scotia Capital’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-30,000
Closed -$2.25M – 743
2016
Q1 		$2.25M Buy
+30,000
New +$2.26M 0.05% 225

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Scotia Capital's MDT Position: Q2 2026 in Review

Scotia Capital reduced its Medtronic (MDT) stake by 8.3% in Q2 2026, selling an estimated $5.84M and leaving 800,957 shares worth $62.7M. The position accounts for 0.23% of the portfolio, ranked #74.

Scotia Capital first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $94.9M in Q3 2024. 2,135 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Scotia Capital held 800,957 shares of Medtronic worth $62.7M as of Q2 2026.
  • Scotia Capital sold 72,418 Medtronic shares in Q2 2026, an estimated $5.84M.
  • Medtronic made up 0.23% of Scotia Capital's portfolio in Q2 2026, its #74 holding.
  • Scotia Capital first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Scotia Capital's Medtronic position peaked at $94.9M in Q3 2024.
  • 2,135 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Scotia Capital's 13F filing for Q2 2026, filed 11 Aug 2026.